Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

UN-SPIDER expert appointed at UFS Risk Management Centre
2017-06-02

Description: Dr Joerg Szarzynski Tags: Dr Joerg Szarzynski

Dr Joerg Szarzynski, head of the EduSphere section
and Education Programme Director at the
United Nations University, Institute for Environment
and Human Security.
Photo: Supplied

“This new development will strengthen the long-lasting collaboration between DiMTEC and the United Nations University, Institute for Environment and Human Security (UNU-EHS) in Bonn in Germany. This [collaboration] goes back for almost a decade of joint training courses and increasingly also includes collaboration in the frame of scientific projects, especially in Africa.”

These were the words of Dr Joerg Szarzynski after his appointment as Affiliated Associate Professor to the Disaster Management Training and Education Centre for Africa (DiMTEC) at the University of the Free State (UFS). Dr Szarzynski will assume his new position with immediate effect.
 
The United Nations University (UNU) is a global thinktank and postgraduate teaching organisation headquartered in Japan.

Dr Szarzynski, head of the EduSphere section and Education Programme Director at UNU-EHS, brings with him a wealth of experience, including serving as senior expert to the United Nations Platform for Space-based Information for Disaster Management and Emergency Response (UN-SPIDER). Within the team, he was principal desk officer for Africa responsible for relief activities after natural disasters, technical consultation, information management, collaborative network development and the cluster on health and climate change adaptation. He also has broad expertise in climatology and remote sensing, global environmental change research, capacity-building and web-based data and information management.

“Dr Szarzynski’s appointment brings
new research opportunities.”

Lecture focus on vulnerability and disaster risk reduction
As part of his new academic responsibilities, Dr Szarzynski will conduct face-to-face lectures during a course on vulnerability and disaster risk-reduction. With this course the centre aims to increase awareness of the complexity and importance of vulnerability and resilience in the field of disaster risk management. Dr Szarzynski’s teachings will focus on Early Warning Systems and Geospatial Technologies in Support of Disaster Risk Reduction (DRR) and Emergency Response Preparedness. He will also lead courses on Assessment and Coordination in International Disaster Management and Humanitarian Response and Information Technology in Disaster Risk Reduction and Disaster Management.

Furthermore he will give lectures via distance learning for the wider curriculum at DiMTEC.

Collaboration between DiMTEC and UNU
Dr Andries Jordaan, Director of DiMTEC at the UFS said: “His appointment opens new networks within the United Nations system, which brings new research opportunities. Furthermore, his expertise is important to us. He has already provided input and delivered lectures through Skype in the course of Information Technology and Communication.”

Dr Szarzynski has been lecturing for the past 10 years in the UFS’ international PhD curriculum.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept